Current status of HIV protease inhibitors
Yang, Q-gang.; He, X-chang.; Bai, D-lu.
Yao Xue Xue Bao 40(5): 389-394
2005
ISSN/ISBN: 0513-4870 PMID: 16220778 Document Number: 587440
Document emailed within 1 workday
Related Documents
Sumathi, S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part II-protease inhibitors of seeds Indian Journal of Biochemistry and Biophysics 13(1): 52-56Bhat, P.G.; Karnik, S.S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part III-purification of protease inhibitors from Lathyrus sativus seeds Indian Journal of Biochemistry and Biophysics 13(4): 339-343
Rao, N.M.; Pattabiraman, T.N. 1985: Natural plant enzyme inhibitors: comparison of the action of tuber protease inhibitors on animal pancreatic systems Indian Journal of Biochemistry and Biophysics 22(6): 373-375
Kobayashi, R.; Hidaka, H. 1991: Enzyme inhibitors--current status and future scope Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 1966-1971
Löffler, B.M. 2000: Endothelin-converting enzyme inhibitors: current status and perspectives Journal of Cardiovascular Pharmacology 35(4 Suppl 2): S79-S82
Malcolm, J.; Malcolm-Thomas, B.; Comhaire, E. 1970: Current status of knowledge concerning adrenergic beta receptor inhibitors Acta Cardiologica 25(3): 260-279
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Aoyagi, T. 1978: Protease inhibitors Seikagaku. Journal of Japanese Biochemical Society 50(5): 358-365
Silbermann, B.; Yousry, C.; Salmon-Céron, D. 2000: HIV protease inhibitors Annales de Medecine Interne 151(4): 268-277
Worowski, K.; Roszkowska, W. 1979: Protease inhibitors in potatoes Postepy Biochemii 25(2): 229-246
Manrique, R. 1984: Protease inhibitors and antifibrinolytic therapy Arquivos Brasileiros de Cardiologia 43(5): 355-360
Bouvier, C.A. 1975: Indications and contraindications for protease inhibitors Schweizerische Medizinische Wochenschrift 105(37): 1191-1195
Torres, G. 1996: Tuberculosis therapy and the new protease inhibitors Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 10(11): 11-12
Mullakandov, S.A.; Gafarov, E.K.; Nabiev, U.A. 1985: Use of protease inhibitors on burn patients Klinicheskaia Khirurgiia 3: 43-44
Scheibel, L.W.; Bueding, E.; Fish, W.R.; Hawkins, J.T. 1984: Protease inhibitors and antimalarial effects Progress in Clinical and Biological Research 155: 131-142
Kennedy, A.R. 1994: Prevention of carcinogenesis by protease inhibitors Cancer Research 54(7 Suppl): 1999s-2005s
Cohen, J. 1996: Protease inhibitors: a tale of two companies Science 272(5270): 1882-1883
Zimmerman, J.J. 1999: What's the buzz (on protease inhibitors)...tell me what's (mechanistically) happening Critical Care Medicine 27(9): 2062-2063
Manchanda, T.; Schiedel, D.; Fischer, D.; Dekaban, G.A.; Rieder, M.J. 2002: Adverse drug reactions to protease inhibitors Canadian Journal of Clinical Pharmacology 9(3): 137-146
Sommadossi; Murphy 1997: Protease Inhibitors Therapy for AIDS Patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 1(5): 226-229